vs
Side-by-side financial comparison of Franklin BSP Realty Trust, Inc. (FBRT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Franklin BSP Realty Trust, Inc. is the larger business by last-quarter revenue ($81.1M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 25.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 22.6%).
Franklin BSP Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) focused on originating, investing in, and managing a diversified portfolio of commercial real estate debt assets, including first mortgage loans, mezzanine financing and other credit-related real estate products. It operates primarily in the U.S. market, targeting consistent risk-adjusted returns and stable income distributions for investors.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FBRT vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $81.1M | $75.5M |
| Net Profit | $18.4M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 22.7% | — |
| Revenue YoY | 25.8% | 27.7% |
| Net Profit YoY | -39.1% | — |
| EPS (diluted) | $0.13 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $81.1M | $75.5M | ||
| Q3 25 | $89.5M | $54.5M | ||
| Q2 25 | $49.3M | $52.4M | ||
| Q1 25 | $50.1M | $46.0M | ||
| Q4 24 | $64.5M | $59.1M | ||
| Q3 24 | $54.0M | $80.5M | ||
| Q2 24 | $50.9M | $47.1M | ||
| Q1 24 | $54.0M | $43.8M |
| Q4 25 | $18.4M | — | ||
| Q3 25 | $17.3M | $8.8M | ||
| Q2 25 | $23.2M | $5.9M | ||
| Q1 25 | $24.1M | $3.0M | ||
| Q4 24 | $30.2M | — | ||
| Q3 24 | $31.6M | $20.3M | ||
| Q2 24 | $-2.2M | $-4.5M | ||
| Q1 24 | $35.9M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | 22.7% | — | ||
| Q3 25 | 19.3% | 16.2% | ||
| Q2 25 | 47.1% | 11.2% | ||
| Q1 25 | 48.0% | 6.5% | ||
| Q4 24 | 46.8% | — | ||
| Q3 24 | 58.5% | 25.2% | ||
| Q2 24 | -4.3% | -9.6% | ||
| Q1 24 | 66.6% | -11.0% |
| Q4 25 | $0.13 | $0.26 | ||
| Q3 25 | $0.12 | $0.17 | ||
| Q2 25 | $0.19 | $0.12 | ||
| Q1 25 | $0.20 | $0.06 | ||
| Q4 24 | $0.28 | $0.40 | ||
| Q3 24 | $0.30 | $0.41 | ||
| Q2 24 | $-0.11 | $-0.09 | ||
| Q1 24 | $0.35 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $1.4B | $130.3M |
| Total Assets | $6.1B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $97.5M | ||
| Q3 25 | $116.7M | $94.4M | ||
| Q2 25 | $414.1M | $96.0M | ||
| Q1 25 | $215.4M | $93.2M | ||
| Q4 24 | $184.4M | $101.0M | ||
| Q3 24 | $346.2M | $96.7M | ||
| Q2 24 | $94.8M | $96.8M | ||
| Q1 24 | $240.0M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $1.4B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.5B | $104.7M | ||
| Q1 25 | $1.5B | $97.1M | ||
| Q4 24 | $1.5B | $92.1M | ||
| Q3 24 | $1.5B | $71.1M | ||
| Q2 24 | $1.5B | $48.5M | ||
| Q1 24 | $1.6B | $51.0M |
| Q4 25 | $6.1B | $216.3M | ||
| Q3 25 | $6.2B | $202.9M | ||
| Q2 25 | $5.6B | $194.9M | ||
| Q1 25 | $5.7B | $196.2M | ||
| Q4 24 | $6.0B | $213.3M | ||
| Q3 24 | $6.3B | $220.7M | ||
| Q2 24 | $6.3B | $205.0M | ||
| Q1 24 | $6.0B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $291.9M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 15.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $291.9M | $14.4M | ||
| Q3 25 | $-148.1M | $9.7M | ||
| Q2 25 | $11.8M | $14.1M | ||
| Q1 25 | $116.2M | $3.6M | ||
| Q4 24 | $57.2M | $15.6M | ||
| Q3 24 | $97.4M | $11.0M | ||
| Q2 24 | $1.9M | $1.0M | ||
| Q1 24 | $13.0M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 15.88× | — | ||
| Q3 25 | -8.56× | 1.10× | ||
| Q2 25 | 0.51× | 2.41× | ||
| Q1 25 | 4.83× | 1.21× | ||
| Q4 24 | 1.90× | — | ||
| Q3 24 | 3.08× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FBRT
| New Point Holdings JVLLC | $77.3M | 95% |
| Other | $2.1M | 3% |
| Office Building | $1.7M | 2% |
PBYI
Segment breakdown not available.
